CYTOSORBENTS CORPORATION Lessee, Operating Lease, Liability, to be Paid
CYTOSORBENTS CORPORATION (CTSO) had Lessee, Operating Lease, Liability, to be Paid of $19.88 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue · last filed 2026-08-06
- 2026-06-30: Lessee, Operating Lease, Liability, to be Paid $19.88M.
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid $20.31M.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid $20.75M.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid $21.18M.
| Period end | Lessee, Operating Lease, Liability, to be Paid |
|---|---|
| 2026-06-30 | $19.88M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $20.31M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $20.75M 10-K · filed 2026-03-30 |
| 2025-09-30 | $21.18M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $21.60M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $22.02M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $22.44M 10-K · filed 2025-03-31 |
| 2024-09-30 | $22.86M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $23.27M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $23.69M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $24.10M 10-K · filed 2024-03-15 |
| 2023-09-30 | $24.16M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $24.56M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $24.96M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $25.36M 10-K · filed 2023-03-09 |
| 2022-09-30 | $25.83M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $26.28M 10-Q · filed 2022-08-02 |
| 2022-03-31 | $26.76M 10-Q · filed 2022-05-03 |
| 2021-12-31 | $27.26M 10-K · filed 2022-03-10 |
| 2021-09-30 | $27.43M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $26.96M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $923.96K 10-Q · filed 2021-05-04 |
| 2020-12-31 | $1.03M 10-K · filed 2021-03-09 |
| 2020-09-30 | $1.13M 10-Q · filed 2020-11-04 |
| 2020-06-30 | $1.23M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $970.18K 10-Q · filed 2020-05-05 |
| 2019-12-31 | $1.07M 10-K · filed 2020-03-05 |
| 2019-09-30 | $1.17M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $1.27M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $1.36M 10-Q · filed 2019-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |